6618 logo

JD Health International Stock Price

Symbol: SEHK:6618Market Cap: HK$161.0bCategory: Consumer Retailing

6618 Share Price Performance

Community Fair Values

Recent 6618 News & Updates

No updates

JD Health International Inc. Key Details

CN¥58.2b

Revenue

CN¥44.9b

Cost of Revenue

CN¥13.3b

Gross Profit

CN¥9.1b

Other Expenses

CN¥4.2b

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Aug 14, 2025
Earnings per share (EPS)
1.30
Gross Margin
22.88%
Net Profit Margin
7.16%
Debt/Equity Ratio
0%

JD Health International Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About 6618

Founded
2014
Employees
3564
CEO
Enlin Jin
WebsiteView website
ir.jdhealth.com

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People’s Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

Chinese Market Performance

  • 7 Days: 1.4%
  • 3 Months: 12.7%
  • 1 Year: 30.0%
  • Year to Date: 13.1%
Over the last 7 days, the market has risen 1.4%, driven by gains of 4.0% in the Information Technology sector. The market is up 30% over the last 12 months. As for the next few years, earnings are expected to grow by 23% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading